The approval allows for the delivery system’s use alongside the Amplatzer Piccolo occluder.
EDX’s test is mooted to become the most advanced colorectal cancer testing service ever offered in the UK.
The study is designed to assess uTREAT as a targeted radiopharmaceutical therapy in patients newly diagnosed with GBM.
Healthcare professionals in most regions of the US can order the test for women who previously had a child diagnosed with autism.
The KPAP sleep therapy platform is developed to offer an adaptive and patient-focused alternative to traditional CPAP therapy.
CMR Surgical’s Versius Plus robot’s clearance follows the FDA’s de novo classification of the company’s first-generation Versius robot in October 2024.
